| 1 |
Liu C, Zhan HL, Huang ZH, et al. Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism[J]. BMC Pulm Med, 2020, 20(1): 180.
|
| 2 |
欧敏,王斌,张明周,等. 心电图及心脏超声在急性肺栓塞诊断及危险分层中的意义[J/OL]. 中华肺部疾病杂志(电子版), 2022, 15(4): 502-505.
|
| 3 |
常人元,雷涛,王彤,等. rt-PA剂量对中高危急性肺栓塞患者超声辅助置管溶栓期间肺动脉压和出血风险的影响[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(1): 42-48.
|
| 4 |
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Kardiol Pol, 2014, 72(11): 997-1053.
|
| 5 |
Becattini C, Agnelli G. Risk stratification and management of acute pulmonary embolism[J]. Hematology Am Soc Hematol Educ Program, 2016(1): 404-412.
|
| 6 |
Zhai ZG, Wang DY, Lei JP, et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: An analysis from the China Pulmonary thromboembolism Registry Study (CURES)[J]. Eur Respir J, 2021, 58(4): 2002963.
|
| 7 |
de Wit Kerstin, D′Arsigny Christine L. Risk stratification of acute pulmonary embolism[J]. J Thromb Haemost, 2023, 21(11): 3016-3023.
|
| 8 |
Task Force on Pulmonary embolism, European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2000, 21(16): 1301-1336.
|
| 9 |
Harshwardhan K, Pankaj H, Vinod K, et al. Acute pulmonary embolism:Diagnosis and management[J]. Indian Heart J, 2023, 75(5): 335-342.
|
| 10 |
魏卿,王昌明. 血浆B型脑钠肽结合D-二聚体对肺栓塞预后评估的临床价值[J]. 医学研究杂志,2015, 44(11): 143-146.
|
| 11 |
Trung P, Yevgeniy B, Jawed F, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict all-cause mortality in acute pulmonary embolism[J]. Clin Appl Thromb Hemost, 2020, 26: 1076029619900549.
|
| 12 |
Murat G, Alparslan K. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index[J]. Scand Cardiovasc J, 2021, 55(2): 91-96.
|
| 13 |
Zeng R, Liu F, Fang C, et al. PIV and PILE score at baseline predict clinical outcome of anti-PD-1/PD-L1 inhibitor combined with chemotherapy in extensive-stage small cell lung cancer patients[J]. Front Immunol, 2021, 12: 724443.
|
| 14 |
王靖远,段降龙. 泛免疫炎症值在临床应用中的研究进展[J]. 临床医学进展,2026, 16(2): 1122-1127.
|
| 15 |
李丽华,武云. 新型炎症指标对急性肺栓塞诊断及预后价值研究进展[J]. 现代医药卫生,2024, 40(4): 650-654.
|
| 16 |
Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology(ESC)[J]. Eur Respir J, 2019, 54(3): 1901647.
|
| 17 |
李悦鑫,刘儒,郭璐映,等. 心电图联合PESI评分在急性肺栓塞病情分层及预后预测中的价值[J]. 河南医学研究,2024, 33(2): 303-307.
|
| 18 |
王沛然,孙凯,徐希奇.《急性肺栓塞诊断和治疗指南2025》解读[J]. 协和医学杂志,2026, 17(1): 140-147.
|
| 19 |
Konstantinides SV, Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2019, 40(42): 3453-3455.
|
| 20 |
Panova-Noeva M, Wagner B, Nagler M, et al. Variation of platelet function in clinical phenotypes of acute venous thromboembolism-Results from the GMP-VTE project[J]. J Thromb Haemost, 2022, 20(3): 705-715.
|
| 21 |
Jo JY, Lee MY, Lee JW, et al. Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patients[J]. BMC Pulm Med, 2013, 13: 74.
|
| 22 |
Louise MI, Jasmin W, Christoph S. Control of leukocyte trafficking by stress-associated hormones[J]. Front Immunol, 2019, 9: 3143.
|
| 23 |
Colling ME, Tourdot BE, Kanthi Y. Inflammation, infection and venous thromboembolism[J]. Circ Res, 2021, 128 (12): 2017-2036.
|
| 24 |
朱婕琳. 老年急性肺栓塞患者外周血单核细胞、中性粒细胞、白细胞变化及临床意义[J]. 中国现代医生,2021, 59(11): 10-12.
|
| 25 |
Zhu MK, Zhou YH, Liu ZF, et al . Diagnostic efficiency of pan-immune-inflammation value to predict prostate cancer in patients with prostate-specific antigen between 4 and 20 ng/ml[J]. J Clin Med, 2023, 12(3): 820.
|
| 26 |
Chen YQ, Gong LY, Gu PY, et al. Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy[J]. BMC Cancer, 2023, 23(1): 944.
|
| 27 |
李丽华,魏猛,王瑞,等. D-二聚体联合中性粒细胞与淋巴细胞比值诊断急性肺栓塞的列线图预测模型构建及验证[J]. 临床内科杂志,2025, 42(1): 30-34.
|
| 28 |
何丽,赵玲,施磊,等. 血浆D-二聚体及纤维蛋白原对肺栓塞危险分层的意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(1): 137-139.
|
| 29 |
陈青山,章智荣,董红红,等. 胸部恶性肿瘤围术期静脉血栓栓塞症预防中国专家共识(2018版)[J]. 中国肺癌杂志,2019, 22(12): 761-766.
|
| 30 |
张俊华,张卉卉,王华英. 血清前白蛋白及新型炎症指标与急性肺栓塞风险分层的相关性分析[J]. 现代实用医学,2025, 37(10): 1067-1068.
|